News & Blog

Capsida Biotherapeutics to Present New Preclinical Data for Friedreich’s Ataxia Next-Generation Gene Therapy to Target CNS, Cardiac Tissues and Sensory Regions

Global Ataxia Advocacy Organizations Unite to Host Largest International Congress for Ataxia Research in London

Meet The Community: Aidan LeCompte

Webinar Recording: An Informational Webinar Hosted by Larimar Therapeutics — November 2024

2024 rideATAXIA Philly and FARA & CHOP FA Symposium Recap

Meet The Community: Daniel Huber

Meet The Community: Kendall Harvey

Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia

2024 rideATAXIA Hometown Twin Cities, MN Recap

PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program

Meet the Community 2: A Closer Look — Alijana Shakya 

2024 Fuzzy Buzzy Recap